Cargando…

The Dose-Dependent Effects of Spironolactone on TGF-β1 Expression and the Vulnerability to Atrial Fibrillation in Spontaneously Hypertensive Rats

OBJECTIVE: This study tends to assess the dose-dependent effects of spironolactone on TGF-β1 expression, atrial fibrosis, and the vulnerability to atrial fibrillation in spontaneously hypertensive rats (SHRs) and tries to clarify the association of atrial fibrosis with the vulnerability to atrial fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Mirong, Chen, Yan, Sun, Fuqing, Yan, Liangliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490048/ https://www.ncbi.nlm.nih.gov/pubmed/34616570 http://dx.doi.org/10.1155/2021/9924381

Ejemplares similares

Silencing of TLR4 Inhibits Atrial Fibrosis and Susceptibility to Atrial Fibrillation via Downregulation of NLRP3-TGF-β in Spontaneously Hypertensive Rats
por: Ge, Chenliang, et al.
Publicado: (2022)

Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS‐AF Trial
por: Shantsila, Eduard, et al.
Publicado: (2020)

Effects of spironolactone in spontaneously hypertensive adult rats subjected to high salt intake
por: Baldo, Marcelo Perim, et al.
Publicado: (2011)

PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin‐II by reducing TGF‐β1/Smads pathway activation
por: Hu, Juan, et al.
Publicado: (2021)

Selective blocking of CXCR2 prevents and reverses atrial fibrillation in spontaneously hypertensive rats
por: Zhang, Yun‐Long, et al.
Publicado: (2020)

Radiofrequency catheter ablation combined with spironolactone in the treatment of atrial fibrillation: A single‐center randomized controlled study
por: Wang, Weiwei, et al.
Publicado: (2021)

Salidroside attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II through inhibition of LOXL2-TGF-β1-Smad2/3 pathway
por: Hai, Zhen, et al.
Publicado: (2023)

Aerobic Interval Training Prevents Age-Dependent Vulnerability to Atrial Fibrillation in Rodents
por: Malmo, Vegard, et al.
Publicado: (2018)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Left atrial effective conducting size predicts atrial fibrillation vulnerability in persistent but not paroxysmal atrial fibrillation
por: Williams, Steven E., et al.
Publicado: (2019)

Downregulation of fibromodulin attenuates inflammatory signaling and atrial fibrosis in spontaneously hypertensive rats with atrial fibrillation via inhibiting TLR4/NLRP3 signaling pathway
por: Liang, Yuming, et al.
Publicado: (2023)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

miR-328 - a novel diagnostic and predictive atrial fibrillation biomarker in spontaneously hypertensive rats
por: Scridon, A, et al.
Publicado: (2023)

Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-β1/Smad2/3 Induces Atrial Fibrosis in Aging and Spontaneously Hypertensive Rats
por: He, Rongfang, et al.
Publicado: (2019)

Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in postoperative atrial fibrillation
por: Zhang, Daoliang, et al.
Publicado: (2017)

Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat
por: Leader, Catherine J., et al.
Publicado: (2020)

Role of serum TGF-β1 level in atrial fibrosis and outcome after catheter ablation for paroxysmal atrial fibrillation
por: Tian, Ye, et al.
Publicado: (2017)

Spironolactone in pulmonary arterial hypertension: results of a cross-over study
por: Safdar, Zeenat, et al.
Publicado: (2020)

Association of spironolactone treatment and arterial stiffness and cardiovascular disease in hypertensive patients
por: Zeng, Fanfang, et al.
Publicado: (2019)

CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post‐Myocardial Infarction Rats
por: Liu, Mingxin, et al.
Publicado: (2019)

LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation
por: Cao, Feng, et al.
Publicado: (2019)

Effect of Spironolactone on Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: Post-Hoc Analysis of the Randomized, Placebo-Controlled TOPCAT Trial
por: Neefs, Jolien, et al.
Publicado: (2019)

Intermedin 1-53 Ameliorates Atrial Fibrosis and Reduces Inducibility of Atrial Fibrillation via TGF-β1/pSmad3 and Nox4 Pathway in a Rat Model of Heart Failure
por: Ma, Shenzhou, et al.
Publicado: (2023)

Atrial Fibrillation in Hypertension: Patients’ Characteristics
por: Koutsaki, Styliani, et al.
Publicado: (2018)

The Early Stage of the Atrial Electroanatomic Remodeling as Substrates for Atrial Fibrillation in Hypertensive Patients
por: Yin, Xiaomeng, et al.
Publicado: (2014)

Doxycycline Improves Fibrosis-Induced Abnormalities in Atrial Conduction and Vulnerability to Atrial Fibrillation in Chronic Intermittent Hypoxia Rats
por: Ma, Zuowang, et al.
Publicado: (2020)

A new procedure for elimination of atrial fibrillation associated with mitral valve disease: a proof-of-concept study
por: Chen, Liangwan, et al.
Publicado: (2023)

Spontaneous conversion of atrial fibrillation caused by severe hyperkalemia: A case report
por: Yan, Lihua, et al.
Publicado: (2018)

IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial
por: Shantsila, Eduard, et al.
Publicado: (2016)

Losartan Attenuates Myocardial Endothelial-To-Mesenchymal Transition in Spontaneous Hypertensive Rats via Inhibiting TGF-β/Smad Signaling
por: Wu, Miao, et al.
Publicado: (2016)

Suppression of TGF-β(1)/Smad Signaling Pathway by Sesamin Contributes to the Attenuation of Myocardial Fibrosis in Spontaneously Hypertensive Rats
por: Zhao, Mengqiu, et al.
Publicado: (2015)

EPA-Enriched Phospholipids Alleviate Renal Interstitial Fibrosis in Spontaneously Hypertensive Rats by Regulating TGF-β Signaling Pathways
por: Shi, Hao-Hao, et al.
Publicado: (2022)

Atrial Arrhythmia in Ageing Spontaneously Hypertensive Rats: Unraveling the Substrate in Hypertension and Ageing
por: Lau, Dennis H., et al.
Publicado: (2013)

TGF-β1–induced endothelial-mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation?
por: Saljic, Arnela, et al.
Publicado: (2022)

Spironolactone-Induced Unilateral Gynecomastia
por: Veeregowda, Sahana Hadihalli, et al.
Publicado: (2018)

Efficacy of low-dose spironolactone on top of angiotensin receptor blockade in patients with glomerulonephritis
por: Yu, Byung Chul, et al.
Publicado: (2018)

The atrial fibrillation paradox -connecting hypertension to atrial disease and stroke
por: Mendys, Phil, et al.
Publicado: (2021)

Impact of effective refractory period personalization on prediction of atrial fibrillation vulnerability
por: Martinez Diaz, P, et al.
Publicado: (2023)

The Effect of Spironolactone on β-amyloid-Induced Memory Impairment in Male Rats: The Role of Microglial Inhibition
por: Mehdipour, Mohammad, et al.
Publicado: (2022)

Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer
por: Huang, Huocong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0l3pir2etg740u0u377drvqldj